Search Results - "Valduga, F" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

by Ghi, M.G., Paccagnella, A., Ferrari, D., Foa, P., Alterio, D., Codecà, C., Nolè, F., Verri, E., Orecchia, R., Morelli, F., Parisi, S., Mastromauro, C., Mione, C.A., Rossetto, C., Polsinelli, M., Koussis, H., Loreggian, L., Bonetti, A., Campostrini, F., Azzarello, G., D’Ambrosio, C., Bertoni, F., Casanova, C., Emiliani, E., Guaraldi, M., Bunkheila, F., Bidoli, P., Niespolo, R.M., Gava, A., Massa, E., Frattegiani, A., Valduga, F., Pieri, G., Cipani, T., Da Corte, D., Chiappa, F., Rulli, E.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

EP-1110: Chemo-radiotherapy for patients with H&N cancer: evaluation of acute toxicity based on intensity of supportive care

EP-1110: Chemo-radiotherapy for patients with H&N cancer: evaluation of acute toxicity based on intensity of supportive care

by Vanoni, V, Magri, E, Bolner, A, Caldara, A, Valduga, F, Tomio, L
Published in Radiotherapy and oncology (01.03.2013)

Get full text

Journal Article

Pain and quality of life after surgery for breast cancer

Pain and quality of life after surgery for breast cancer

by CAFFO, Orazio, AMICHETTI, Maurizio, FERRO, Antonella, LUCENTI, Antonio, VALDUGA, Francesco, GALLIGIONI, Enzo
Published in Breast cancer research and treatment (01.07.2003)

Get full text

Journal Article

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience

by Galligioni, E., Berloffa, F., Caffo, O., Tonazzolli, G., Ambrosini, G., Valduga, F., Eccher, C., Ferro, A., Forti, S.
Published in Annals of oncology (01.02.2009)

Get full text

Journal Article

EP-1018: Impact of HPV status on the outcome of oropharyngeal cancer treated with advanced radiotherapy techniques

EP-1018: Impact of HPV status on the outcome of oropharyngeal cancer treated with advanced radiotherapy techniques

by Vanoni, V, Bolner, A, Magri, E, Mussari, S, Valduga, F, Caldara, A, Bragantini, E, Menegotti, L, Tomio, L
Published in Radiotherapy and oncology (01.03.2013)

Get full text

Journal Article

7050 POSTER Multiple Docetaxel (DOC) Re-challenges (ReC) in Castration-resistant Prostate Cancer (CRPC) Patients (pts) – Outcomes and Predictive Factors of Response

7050 POSTER Multiple Docetaxel (DOC) Re-challenges (ReC) in Castration-resistant Prostate Cancer (CRPC) Patients (pts) – Outcomes and Predictive Factors of Response

by Caffo, O, Caldara, A, Ferro, A, Frisinghelli, M, Murgia, V, Soini, B, Valduga, F, Veccia, A, Pappagallo, G, Galligioni, E
Published in European journal of cancer (1990) (2011)

Get full text

Journal Article

Sleep quality and correlation between anthropometry and elderly women of the senior UCS program

Sleep quality and correlation between anthropometry and elderly women of the senior UCS program

by Theodoro, H., Valduga, F., Siviero, J.
Published in Sleep medicine (01.12.2019)

Get full text

Journal Article

Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years

Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years

by PASINI, F, VERLATO, G, DURANTE, E, DE MANZONI, G, VALDUGA, F, ACCORDINI, S, PEDRAZZANI, C, TERZI, A, PELOSI, G
Published in British journal of cancer (02.06.2003)

Get full text

Journal Article

4237 Development and daily use of a nurses electronic diary form, for hospitalized patients

4237 Development and daily use of a nurses electronic diary form, for hospitalized patients

by Campregher, M, Lazzeri, S, Modena, E, Valduga, F, Galligioni, E
Published in European journal of cancer supplements (2009)

Get full text

Journal Article

7171 Chemoradiotherapy with cisplatin (C) and gemcitabine (G) plus concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients – clinical outcome and long term follow-up in a monoinstitutional experience

7171 Chemoradiotherapy with cisplatin (C) and gemcitabine (G) plus concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients – clinical outcome and long term follow-up in a monoinstitutional experience

by Caffo, O, Fellin, G, Graffer, U, Mussari, S, Arcuri, C, Caldara, A, Murgia, V, Valduga, F, Tomio, L, Galligioni, E
Published in European journal of cancer supplements (2009)

Get full text

Journal Article

Concurrent chemoradiotherapy (cCTRT) with weekly cisplatin (wCDDP) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience

Concurrent chemoradiotherapy (cCTRT) with weekly cisplatin (wCDDP) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience

by Murgia, V., Caffo, O., Caldara, A., Brugnara, S., Dipasquale, M., Ferro, A., Frisinghelli, M., Macrini, S., Maines, F., Daniela, M., Trentin, C., Valduga, F., Veccia, A., Galligioni, E.
Published in Annals of oncology (01.10.2015)

Get full text

Journal Article

Nonlinear time-resolved spectroscopy with extremely high temporal dynamic range

Nonlinear time-resolved spectroscopy with extremely high temporal dynamic range

by Flory, T., Stummer, V., Pupeikis, J., Willenberg, B., Nussbaum-Lapping, A., De Almeida Camargo, F. Valduga, Barkauskas, M., Phillips, C. R., Keller, U., Cerullo, G., Pugzlys, A., Baltuska, A.
Published in 2023 Conference on Lasers and Electro-Optics (CLEO) (01.05.2023)

Get full text

Conference Proceeding

Neoadjuvant Chemotherapy (NC) with or without Anthracyclines in different Invasive Breast Cancer (IBC) subtypes: outcomes according to pathological complete response (pCR) and proliferation index (PI) of residual tumor (RT)

Neoadjuvant Chemotherapy (NC) with or without Anthracyclines in different Invasive Breast Cancer (IBC) subtypes: outcomes according to pathological complete response (pCR) and proliferation index (PI) of residual tumor (RT)

by Ferro, A., Caldara, A., Triolo, R., Caffo, O., Trentin, C., Barbareschi, M., Maines, F., Brugnara, S., Frisinghelli, M., Murgia, V., Dipasquale, M., Valduga, F., Veccia, A., Mangiola, D., Macrini, S., Galligioni, E.
Published in Annals of oncology (01.10.2015)

Get full text

Journal Article

Prognostic Factors and Validation of Prognostic Nomograms in Patients (PTS) Treated with 3 Targeted Therapies (TTS) for Metastatic Renal Cell Carcinoma (MRCC): Results from an Italian Survey

Prognostic Factors and Validation of Prognostic Nomograms in Patients (PTS) Treated with 3 Targeted Therapies (TTS) for Metastatic Renal Cell Carcinoma (MRCC): Results from an Italian Survey

by Iacovelli, R., Rizzo, M., Lorusso, V., Atzori, F., Zucali, P.A., Sacco, C., Boccardo, F., Valduga, F., Massari, F., Procopio, G.
Published in Annals of oncology (01.09.2012)

Get full text

Journal Article

Assessment of clinical outcomes and prognostic factors in patients (pts) with non-small cell lung carcinoma (NSCLC) and brain metastases (BM). Results from a single institution study

Assessment of clinical outcomes and prognostic factors in patients (pts) with non-small cell lung carcinoma (NSCLC) and brain metastases (BM). Results from a single institution study

by Dipasquale, M., Caffo, O., Murgia, V., Veccia, A., Bolner, A., Brugnara, S., Caldara, A., Fellin, G., Ferro, A., Frisinghelli, M., Magri, E., Maines, F., Mussari, S., Nagliati, M., Pani, G., Proto, T., Trentin, C., Valduga, F., Vanoni, V., Tomio, L., Galligioni, E.
Published in Annals of oncology (01.10.2015)

Get full text

Journal Article

O5 Progression free survival (PFS) and overall survival (OS) in patients receiving 3 targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)

O5 Progression free survival (PFS) and overall survival (OS) in patients receiving 3 targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)

by Iacovelli, R, Milella, M, Santoni, M, Di Lorenzo, G, Cerbone, L, Ortega, C, Masini, C, Giganti, M.O, Messina, C, De Vincenzo, F, Baratelli, C, Massari, F, Boccardo, F, Sacco, C, Mosca, A, Atzori, F, Lorusso, V, Valduga, F, Baldazzi, V, Cinieri, S, Primi, F, Procopio, G
Published in European urology supplements : official journal of the European Association of Urology (01.11.2012)

Get full text

Journal Article

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Second-Line Chemotherapy With Irinotecan Plus Carmustine in Glioblastoma Recurrent or Progressive After First-Line Temozolomide Chemotherapy: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

by BRANDES, Alba A, TOSONI, Alicia, BASSO, Umberto, RENI, Michele, VALDUGA, Francesco, MONFARDINI, Silvio, AMISTA, Pietro, NICOLARDI, Linda, SOTTI, Guido, ERMANI, Mario
Published in Journal of clinical oncology (01.12.2004)

Get full text

Journal Article

838PCHARACTERISTICS AND PROGNOSTIC FACTORS IN 455 ELDERLY PTS OVER 70 WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH TARGET THERAPIES (TT) IN THE COMMUNITY SETTING: AN ITALIAN SURVEY

838PCHARACTERISTICS AND PROGNOSTIC FACTORS IN 455 ELDERLY PTS OVER 70 WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED WITH TARGET THERAPIES (TT) IN THE COMMUNITY SETTING: AN ITALIAN SURVEY

by Fraccon, A.P., Pasini, F., Basso, U., Larussa, F., Valduga, F., Re, G. Lo, Graiff, C., Rosti, G., Bearz, A., Sartori, D., Abeni, C., Grillone, F., Vicario, G., Pegoraro, C., Bassan, F., Da Corte, D., Modonesi, C., Segati, R., Medici, M., Barile, C.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

Characteristics and Prognostic Factors in 455 Elderly Pts Over 70 with Metastatic Renal Cell Carcinoma (Mrcc) Treated with Target Therapies (Tt) in the Community Setting: an Italian Survey

Characteristics and Prognostic Factors in 455 Elderly Pts Over 70 with Metastatic Renal Cell Carcinoma (Mrcc) Treated with Target Therapies (Tt) in the Community Setting: an Italian Survey

by Fraccon, A.P., Pasini, F., Basso, U., Larussa, F., Valduga, F., Re, G. Lo, Graiff, C., Rosti, G., Bearz, A., Sartori, D., Abeni, C., Grillone, F., Vicario, G., Pegoraro, C., Bassan, F., Da Corte, D., Modonesi, C., Segati, R., Medici, M., Barile, C.
Published in Annals of oncology (01.09.2014)

Get full text

Journal Article

Multiple rechallenges (ReCs) with docetaxel (DOC) as an option after first-line therapy in patients (pts) with castration-resistant prostate cancer (CRPC)

Multiple rechallenges (ReCs) with docetaxel (DOC) as an option after first-line therapy in patients (pts) with castration-resistant prostate cancer (CRPC)

by Caffo, O., Brugnara, S., Caldara, A., Ferro, A., Frisinghelli, M., Murgia, V., Soini, B., Valduga, F., Veccia, A., Galligioni, E.
Published in Journal of clinical oncology (01.03.2011)

Get full text

Journal Article